What Causes PMS? Hadassah Study Offers Answer, with Implications for Future Research

Wednesday, Jun 5 2019

A new explanation for the mood swings, irritability, and depression, known as Premenstrual syndrome (PMS) has been suggested by a Hadassah Medical Organization study.

The researchers, in studying 20 men and women, aged 20-30, found that in the week prior to menstruation, the women’s brains processed events and emotions differently. When the women were shown films that had both happy and sad segments, including Disney’s The Lion King, they did not feel the expected joy at the appropriate points in the film, if they were premenstrual.  Men, in contrast, showed no variation in their emotions at different times.

Using functional magnetic resonance imaging (fMRI), the researchers scanned the women twice, first during the mid-follicular phase of their cycle and then during the late-luteal menstrual phases. When the women were premenstrual, their neural activity was diminished. In addition, when the researchers looked at the neural findings against the women’s reports of experiencing reduced amusement and increased sadness, they found that the findings complemented one another.

The study was conducted by Prof. Omer Bonne, head of Hadassah’s Department of Psychiatry, Dr. Inbal Reuveni, senior Hadassah psychiatrist, and Prof. Gadi Goelman of the Hebrew University-Hadassah School of Medicine, along with other colleagues from the Hebrew University.

“The study has far-reaching implications for research that deals with gender differences," said Prof. Goelman. "Its results indicate the need to consider the female hormonal situation in studies examining differences between men and women.”

The next step, Dr. Reuveni explains, is finding treatment for the most severe cases in which three to eight percent of premenstrual women suffer from depression, excessive anger, and anxiety.

Currently, these severe symptoms are treated with psychiatric drugs. The goal of future research, she says, is to find "lighter" drugs, which won’t have serious side effects.

The study is highlighted in the February 2019 issue of Psychoneuroendocrinology.

Learn more about the Hadassah Medical Organization.


No comments yet.
First Name
Enter this word:

Related Stories


Wednesday, Jun 12 2019

Multinational Study Reveals Reduction in Kidney Disease Progression with Diabetes Drug

In a large multinational study that revealed the effectiveness of a medicine called dapagliflozin in reducing cardiovascular death from heart failure among high-risk diabetic patients, the first sub-analysis of renal data has also identified a 47 percent drop in decline of kidney function and renal death.


Wednesday, Jun 5 2019

Hadassah Confronts the Comeback of Measles

Measles, a disease we have not seen for a long time, has come back. In the past year and a half, Israel has seen over 4,000 cases, says Prof. Allon Moses, director of the Department of Clinical Microbiology and Infectious Diseases at the Hadassah Medical Organization.


Wednesday, May 29 2019

First Cath Lab Opens in Northern Neighborhoods of Jerusalem at Hadassah Mount Scopus

Hadassah Hospital Mount Scopus inaugurated the first advanced cardiac catheterization unit serving Jerusalem’s northern neighborhoods.


Wednesday, May 29 2019

It All Began With a Riding Accident

Riding since he was seven, Noam Malmud, an accomplished equestrian, had fallen many times before. But now he was 64, and when a car horn caused his steed to buck and rear, throwing him to the ground, he broke his hip and thighbones.


Donation Questions


(800) 928-0685

Membership Questions


(800) 664-5646

Missions Department


(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005


More ›

Show More